CPC A61K 38/2006 (2013.01) [A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 14/545 (2013.01); A61K 38/08 (2013.01)] | 7 Claims |
1. A method for reducing and/or reducing the likelihood of cancer metastasis in a subject in need thereof, comprising:
administering a therapeutically effective dosage of a pro-interleukin-1α (pro-IL-1α) peptide mimic to the subject to reduce and/or reduce the likelihood of the cancer metastasis,
wherein the pro-IL-1α peptide mimic consists of the amino acid sequence of SEQ ID NO: 1, or
wherein the pro-IL-1α peptide mimic consists of the amino acid sequence of SEQ ID NO: 1 with 1, 2, or 3 amino acid substitutions, deletions or additions.
|